2025-04-08 18:26:47
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Alembic Pharmaceuticals Ltd Q1FY22 consolidated PAT slides to Rs. 164.52 crores
Posted On : 2021-07-26 22:15:01( TIMEZONE : IST )
ALEMBIC PHARMACEUTICALS LTD. has reported financial results for the period ended June 30, 2021.
Financial Results (Q1 FY 2021-22) - QoQ Comparison
The company has reported total income of Rs.1327.91 crores during the period ended June 30, 2021 as compared to Rs.1284.34 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.164.52 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.250.70 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.8.37 for the period ended June 30, 2021 as compared to Rs.12.75 for the period ended March 31, 2021.
| Financials | Q1 FY2021-22 | Q4 FY20-21 | % Change |
| Total Income | ₹ 1327.91 crs | ₹ 1284.34 crs |  3.39% |
| Net Profit | ₹ 164.52 crs | ₹ 250.70 crs |  -34.38% |
| EPS | ₹ 8.37 | ₹ 12.75 | -34.35% |
Financial Results (Q1 FY 2021-22) - YoY Comparison
The company has reported total income of Rs.1327.91 crores during the period ended June 30, 2021 as compared to Rs.1341.64 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.164.52 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.301.46 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.8.37 for the period ended June 30, 2021 as compared to Rs.15.99 for the period ended June 30, 2020.
| Financials | Q1 FY2021-22 | Q1 FY2020-21 | % Change |
| Total Income | ₹ 1327.91 crs | ₹ 1341.64 crs | -1.02% |
| Net Profit | ₹ 164.52 crs | ₹ 301.46 crs | -45.43% |
| EPS | ₹ 8.37 | ₹ 15.99 | -47.65% |
Mr. Pranav Amin, Managing Director, Alembic Pharmaceuticals Limited said "The India business grew exceptionally well and outpaced the Industry, we hope to see this momentum continuing due to the initiatives undertaken recently. The US business faced price erosion due to increased competition. However, our long term view of the US market remains intact."
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs. 910.75 as compared to the previous close of Rs. 946.65. The total number of shares traded during the day was 54314 in over 5466 trades.
The stock hit an intraday high of Rs. 955 and intraday low of 901.1. The net turnover during the day was Rs. 50118652.
